These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 417483)

  • 1. [Neurophysiologic parameters of uremic polyneuropethy as criteria for an optimization of chronic dialysis treatment].
    Knoll O
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1053-6. PubMed ID: 417483
    [No Abstract]   [Full Text] [Related]  

  • 2. [Uremic neuropathies. Comparative study of the velocity of motor and nerve conduction during predialysis, hemodialysis and postransplantation periods].
    Fernández González F
    Arch Neurobiol (Madr); 1976; 39(1):15-36. PubMed ID: 776116
    [No Abstract]   [Full Text] [Related]  

  • 3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motor and sensory nerve conduction in uremic patients undergoing repeated dialysis.
    Codish SD; Cress RH
    Arch Phys Med Rehabil; 1971 Jun; 52(6):260-3. PubMed ID: 5090268
    [No Abstract]   [Full Text] [Related]  

  • 5. Quantified functions of the nervous system in uremic patients on maintenance dialysis.
    Teschan PE; Ginn HE; Walker PJ; Bourne JR; Fristoe M; Ward JW
    Trans Am Soc Artif Intern Organs; 1974; 20A():388-92. PubMed ID: 4450361
    [No Abstract]   [Full Text] [Related]  

  • 6. Variation in nerve conduction velocity in normal and chronic uraemic patients.
    Jajoo UN; Taori GM; Chaubey BS
    J Assoc Physicians India; 1982 Feb; 30(2):93-6. PubMed ID: 7169417
    [No Abstract]   [Full Text] [Related]  

  • 7. F-waves in evaluating uremic polyneuropathy: a long-term study after the application of continuous ambulatory peritoneal dialysis.
    Peioglou-Harmoussi S; Dimitriadis A; Antoniou S; Noitsi-Michali F; Logothetis J
    Funct Neurol; 1987; 2(2):195-205. PubMed ID: 3666549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Variations of neural conduction velocity during hemodialysis in patients with chronic renal failure ].
    Ucles P; Gutiérrez JA; Garbayo A; Pastor L; Barráu J; Muñóz JR
    Rev Clin Esp; 1978 Sep; 150(5):273-6. PubMed ID: 725166
    [No Abstract]   [Full Text] [Related]  

  • 9. Follow-up of nerve conduction in chronic uremic patients during hemodialysis.
    Leone M; Bottacchi E; Alloatti S; Nebiolo PE; Aimino M; Baldini S
    Ital J Neurol Sci; 1992 May; 13(4):317-21. PubMed ID: 1601630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
    Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W
    Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nerve conduction velocity and evoked potentials in uremic patients.
    Codish SD; Cress RH; Looser KG; Cohen RM; Paul BJ
    Arch Phys Med Rehabil; 1972 Apr; 53(4):173-8. PubMed ID: 5022709
    [No Abstract]   [Full Text] [Related]  

  • 12. Electrophysiological studies on uremic patients-comparison of peritoneal dialysis and hemodialysis.
    Hughes JR; Roxe DM; del Greco F; Krumlovsky F; Ghantous W; Ivanovich P; Quintanilla A; Salkin M; Stone N; Reins M
    Clin Electroencephalogr; 1980 Apr; 11(2):73-82. PubMed ID: 7389152
    [No Abstract]   [Full Text] [Related]  

  • 13. Motor action potential (M.A.P.) in the evaluation of uremic peripheral neurone damage: influence of middle molecules (M.M.).
    Coratelli P; Giannattasio M; Corciulo R; Petrarulo F; Passavanti G; Ferrannini E; Amerio A
    Life Support Syst; 1983; 1 Suppl 1():129-32. PubMed ID: 6101046
    [No Abstract]   [Full Text] [Related]  

  • 14. Autonomic function in uremic patients treated by hemodialysis or CAPD and in transplant patients.
    Mallamaci F; Zoccali C; Ciccarelli M; Briggs JD
    Clin Nephrol; 1986 Apr; 25(4):175-80. PubMed ID: 3516480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of the maximal and minimal rate of motor and sensory nerve conduction in chronic uremia patients subjected to periodic hemodialysis].
    Ramelli E; Farinelli A; Tralli G; Gilli P; Squerzanti R
    Minerva Med; 1972 Dec; 63(91):5011-9. PubMed ID: 4644985
    [No Abstract]   [Full Text] [Related]  

  • 16. [Longitudinal EEG study of uremic patients treated by extracorporeal hemodialysis and by intermittent peritoneal dialysis].
    Zysno E; Reichenmiller HE; Durr F
    Rev Neurol (Paris); 1967 Jul; 117(1):128-30. PubMed ID: 6063847
    [No Abstract]   [Full Text] [Related]  

  • 17. Motor nerve conduction indicators in uremic neuropathy.
    Mitz M; Prakash AS; Melvin J; Piering W
    Arch Phys Med Rehabil; 1980 Jan; 61(1):45-8. PubMed ID: 7356822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The peripheral nerve function in chronic renal failure. IX. Recovery after renal transplantation. Electrophysiological aspects (sensory and motor nerve conduction).
    Nielsen VK
    Acta Med Scand; 1974 Mar; 195(3):171-80. PubMed ID: 4595252
    [No Abstract]   [Full Text] [Related]  

  • 19. [Velocity of maximal motor nerve conduction in polyneuropathies of uremic patients subjected to various types of hemodialysis for varying periods of time: values and limitations].
    Savazzi GM; Arisi L; Bignardi L; Rossi E; Cambi V; Allegri L
    Riv Neurol; 1976; 46(1):25-35. PubMed ID: 1013604
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of chronic renal failure, dialysis and transplantation on motor nerve conduction velocity in children.
    Arbus GS; Barnor NA; Hsu AC; Murphy EG; Radde IC
    Can Med Assoc J; 1975 Sep; 113(6):517-20. PubMed ID: 1098759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.